Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SDGR

Schrodinger Inc

Mar 25 • 12:06PM ET

21.39

Dollar change -1.36
Percentage change -5.98	%

Healthcare • Health Information Services • USA • NASD

Peers: REGN GILD BIIB VRTX BMRN NBIX INCY EXEL SAGE IONS

| Held by: IJR ARKG VTI VB IWM VBK VXF IWO SPSM IJT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.58	Insider Own	14.94%	Shs Outstand	63.71M	Perf Week	-6.59%
Market Cap	1.56B	Forward P/E	-	EPS next Y	-2.11	Insider Trans	-0.14%	Shs Float	62.12M	Perf Month	-1.38%
Income	-187.12M	PEG	-	EPS next Q	-0.74	Inst Own	86.65%	Short Float	14.89%	Perf Quarter	10.83%
Sales	207.54M	P/S	7.53	EPS this Y	6.37%	Inst Trans	-1.66%	Short Ratio	9.53	Perf Half Y	7.76%
Book/sh	5.78	P/B	3.70	EPS next Y	12.45%	ROA	-23.01%	Short Interest	9.25M	Perf Year	-22.25%
Cash/sh	5.03	P/C	4.25	EPS next 5Y	25.68%	ROE	-38.58%	52W Range	16.67 - 29.15	Perf YTD	10.89%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-45.98%	ROI	-35.81%	52W High	-26.62%	Beta	1.74
Dividend TTM	-	Quick Ratio	3.31	Sales past 5Y	24.96%	Gross Margin	63.01%	52W Low	28.31%	ATR (14)	1.46
Dividend Ex-Date	-	Current Ratio	3.31	EPS Y/Y TTM	-544.81%	Oper. Margin	-100.85%	RSI (14)	44.91	Volatility	4.54% 6.83%
Employees	891	Debt/Eq	0.28	Sales Y/Y TTM	-4.21%	Profit Margin	-90.16%	Recom	1.55	Target Price	32.09
Option/Short	Yes / Yes	LT Debt/Eq	0.24	EPS Q/Q	-29.80%	Payout	0.00%	Rel Volume	0.50	Prev Close	22.75
Sales Surprise	6.13%	EPS Surprise	-29.63%	Sales Q/Q	19.14%	Earnings	Feb 26 AMC	Avg Volume	970.63K	Price	21.39
SMA20	-2.60%	SMA50	-6.69%	SMA200	3.07%	Trades		Volume	206,983	Change	-5.98%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-02-24	Initiated	Leerink Partners	Outperform	$29
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight	$38
May-05-23	Resumed	Piper Sandler	Overweight	$60
Dec-19-22	Initiated	Goldman	Neutral	$23
Mar-01-22	Initiated	Citigroup	Buy	$55
Nov-19-21	Initiated	Piper Sandler	Overweight	$87
Nov-19-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$82 → $49
Nov-11-21	Downgrade	BofA Securities	Buy → Neutral	$80 → $52
Oct-13-21	Initiated	Berenberg	Buy	$91
Sep-01-21	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$82
May-25-21	Initiated	Craig Hallum	Buy	$85
Nov-23-20	Upgrade	BofA Securities	Neutral → Buy	$74
Oct-12-20	Upgrade	Jefferies	Hold → Buy
Mar-02-20	Initiated	Morgan Stanley	Equal-Weight	$43
Mar-02-20	Initiated	Jefferies	Hold	$42
Mar-02-20	Initiated	BMO Capital Markets	Outperform	$65

Show Previous Ratings

Mar-18-25 08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:30AM	Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-10-25 08:30AM	Schrdinger Expands Board of Directors with Appointment of Bridget van Kralingen (Business Wire) -5.04%
Feb-27-25 10:54AM	Q4 2024 Schrodinger Inc Earnings Call (Thomson Reuters StreetEvents)
02:24AM	Schrodinger Inc (SDGR) Q4 2024 Earnings Call Highlights: Strong Software Growth Amidst Revenue ... (GuruFocus.com)
06:00PM	Loading…
Feb-26-25 06:00PM	Schrodinger, Inc. (SDGR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Schrdinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results (Business Wire)
Feb-25-25 10:30AM	Schrodinger Inc (SDGR) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-24-25 08:30AM	Schrodinger to Participate in Upcoming Investor Conferences (Business Wire)
08:30AM	Schrdinger to Participate in Upcoming Investor Conferences (Business Wire)
Feb-20-25 08:30AM	Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -7.73%
08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-18-25 12:50PM	Why Xpeng (XPEV) and Schrodinger (SDGR) Are Advancing Today (Insider Monkey)
Feb-14-25 03:47PM	Schrodinger Stock Scores IBD Rating Upgrade (Investor's Business Daily)
Feb-12-25 08:30AM	Schrdinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26 (Business Wire)
01:45PM	Loading…
Jan-29-25 01:45PM	Schrödinger (SDGR): Revolutionizing Biopharma with Quantum Mechanics and AI (Insider Monkey)
Jan-24-25 12:32PM	Schrödinger, Inc. (SDGR): Quantum Mechanics Meets AI in Biopharma, Backed by Hunterbrooks Key AI Winner Endorsement (Insider Monkey)
Jan-23-25 03:36PM	Why Schrödinger, Inc. (SDGR) Is Skyrocketing Now (Insider Monkey)
03:43AM	Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last? (Zacks)
Jan-22-25 11:29AM	Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping (Insider Monkey) +14.11%
08:30AM	Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jan-13-25 07:00AM	Schrodinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities (Business Wire)
07:00AM	Schrdinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities (Business Wire)
Dec-17-24 08:30AM	Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-20-24 08:30AM	Schrdinger to Present at Piper Sandler 36th Annual Healthcare Conference (Business Wire)
Nov-19-24 08:30AM	Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-18-24 08:30AM	Schrdinger Broadens and Accelerates Predictive Toxicology Initiative (Business Wire)
06:56AM	Loading…
Nov-13-24 06:56AM	Schrodinger announces expanded license agreement with Novartis (TipRanks)
02:06AM	Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... (GuruFocus.com)
12:54AM	Q3 2024 Schrodinger Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-12-24 11:06AM	Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details (Benzinga) +13.87%
08:05AM	Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
06:50AM	Schrdinger Reports Third Quarter 2024 Financial Results (Business Wire)
06:45AM	Schrdinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis (Business Wire)
Nov-11-24 07:10AM	Schrodinger Inc (SDGR) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com)
Nov-04-24 08:30AM	Schrdinger to Present at Jefferies London Healthcare Conference (Business Wire)
Oct-31-24 08:30AM	Schrdinger to Announce Third Quarter 2024 Financial Results on November 12 (Business Wire)
Oct-23-24 06:01AM	Schrodinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium (Business Wire)
06:01AM	Schrdinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium (Business Wire)
Oct-17-24 08:30AM	Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-09-24 06:06AM	Schrodinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium (Business Wire)
06:06AM	Schrdinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium (Business Wire)
Sep-18-24 08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:20AM	Schrödinger, Inc. (SDGR): A Bull Case Theory (Insider Monkey)
Aug-28-24 07:06PM	Schrödinger, Inc. (SDGR): Among The Best Medical AI Companies (Insider Monkey)
Aug-16-24 08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-14-24 08:30AM	Schrdinger to Present at Morgan Stanley Global Healthcare Conference (Business Wire)
Aug-05-24 11:20AM	The 3 Best Med Tech Stocks to Buy Now (InvestorPlace) -6.03%
Aug-01-24 12:59PM	Q2 2024 Schrodinger Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-31-24 09:57PM	SDGR Stock Earnings: Schrodinger Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
08:00PM	Compared to Estimates, Schrodinger (SDGR) Q2 Earnings: A Look at Key Metrics (Zacks)
06:40PM	Schrodinger, Inc. (SDGR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Schrdinger Reports Strong Second Quarter 2024 Financial Results (Business Wire)
Jul-27-24 07:10AM	3 Small-Cap Stocks to Buy at a 52-Week Low (InvestorPlace)
Jul-26-24 07:00AM	Schrdinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology (Business Wire)
Jul-24-24 10:01AM	Earnings Preview: Schrodinger, Inc. (SDGR) Q2 Earnings Expected to Decline (Zacks)
Jul-22-24 08:07PM	3 Stocks That Could Benefit Big Time From Coming Interest Rate Cuts (InvestorPlace) +8.61%
Jul-17-24 08:58AM	Schrdinger to Announce Second Quarter 2024 Financial Results on July 31 (Business Wire)
Jul-16-24 08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.86%
Jul-03-24 03:11PM	3 Top-Rated Gene Editing Stocks Actually Making Money (InvestorPlace)
Jun-14-24 08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jun-04-24 11:59AM	Qiming's Nisa Leung Made the 2024 Forbes Midas List (PR Newswire)
May-22-24 08:30AM	Schrdinger to Present at Jefferies Global Healthcare Conference (Business Wire)
May-17-24 08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-16-24 07:15AM	7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs (InvestorPlace)
May-15-24 08:45AM	What's the Difference Between Biotech Stocks and TechBio Stocks? (Motley Fool)
May-03-24 03:29PM	Schrödinger, Inc. (NASDAQ:SDGR) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:05PM	Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 03:39AM	Schrodinger Inc (SDGR) Q1 2024 Earnings Call Transcript Highlights: A Mixed Start with ... (GuruFocus.com) -8.19%
May-01-24 10:56PM	SDGR Stock Earnings: Schrodinger Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:55PM	Schrodinger Inc (SDGR) Misses Revenue Expectations in Q1 2024 (GuruFocus.com)
05:15PM	Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:00PM	Schrdinger Reports First Quarter 2024 Financial Results (Business Wire)
Apr-18-24 08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-10-24 08:30AM	Schrdinger to Announce First Quarter 2024 Financial Results on May 1 (Business Wire)
Apr-02-24 04:30PM	5 Healthcare Stocks to Buy for 2024 (InvestorPlace)
Mar-24-24 08:16AM	13 Best Stocks to Buy and Hold According to Bill Gates' Portfolio (Insider Monkey)
Mar-20-24 10:27AM	Schrdinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting (Business Wire)
Mar-19-24 08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-18-24 05:50AM	Billionaire Bill Gates Has 35% of His Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks: Are They No-Brainer Buys? (Motley Fool)
Mar-01-24 07:30AM	The Hot List: 3 AI Stocks Worth Buying on Weakness (InvestorPlace) +5.30%
Feb-29-24 01:50PM	Q4 2023 Schrodinger Inc Earnings Call (Thomson Reuters StreetEvents) -18.84%
10:04AM	Schrödinger, Inc. (NASDAQ:SDGR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 10:30PM	Schrodinger, Inc. (SDGR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) -5.20%
05:55PM	Schrodinger, Inc. (SDGR) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:40PM	Schrodinger Inc (SDGR) Reports Strong Revenue Growth in Q4 and Full-Year 2023 (GuruFocus.com)
04:05PM	Schrdinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results (Business Wire)
Feb-26-24 09:15AM	Countdown to Schrodinger, Inc. (SDGR) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Feb-25-24 09:32PM	Qiming Venture Partners Becomes a UN PRI Signatory (PR Newswire)
Feb-20-24 08:30AM	Schrdinger to Participate in Upcoming Investor Conferences (Business Wire)
Feb-19-24 05:13PM	Double Your Money: 3 Growth Stocks to Grab in 2024 (InvestorPlace)
Feb-16-24 08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +9.43%
Feb-14-24 08:30AM	Schrdinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28 (Business Wire)
Jan-19-24 08:30AM	Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jan-08-24 07:30AM	Schrdinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals (Business Wire)
Dec-29-23 02:37AM	Qiming Venture Partners' Portfolio Company UBTech Listed on Hong Kong Stock Exchange (PR Newswire)

Schrodinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Herman Jenny	SVP & Controller	Mar 06 '25	Sale	21.11	666	14,059	27,349	Mar 07 04:14 PM
Herman Jenny	Officer	Mar 06 '25	Proposed Sale	21.11	666	14,056		Mar 06 04:16 PM
Porges Geoffrey Craig	EVP & CFO	Mar 03 '25	Sale	21.76	5,491	119,484	27,544	Mar 04 05:29 PM
Porges Geoffrey Craig	Officer	Mar 03 '25	Proposed Sale	21.76	5,491	119,481		Mar 03 03:30 PM
Tran Yvonne	EVP, CLO & CPO	Feb 18 '25	Option Exercise	4.34	3,902	16,935	15,037	Feb 19 04:09 PM
Tran Yvonne	EVP, CLO & CPO	Feb 18 '25	Sale	28.00	3,902	109,256	11,135	Feb 19 04:09 PM
YVONNE TRAN	Officer	Feb 18 '25	Proposed Sale	24.85	3,902	96,965		Feb 18 04:27 PM
Abel Robert Lorne	See Remarks	Feb 10 '25	Sale	25.99	1,225	31,838	8,115	Feb 12 04:09 PM
Lorton Kenneth Patrick	EVP, CTO & COO, Software	Feb 11 '25	Sale	24.43	985	24,064	41,076	Feb 12 04:08 PM
Herman Jenny	SVP & Controller	Feb 11 '25	Sale	24.43	859	20,985	18,215	Feb 12 04:07 PM
Tran Yvonne	EVP, CLO & CPO	Feb 11 '25	Sale	24.43	828	20,228	11,135	Feb 12 04:07 PM
Lorton Kenneth Patrick	Officer	Feb 11 '25	Proposed Sale	24.43	985	24,064		Feb 11 06:34 PM
Herman Jenny	Officer	Feb 11 '25	Proposed Sale	24.43	859	20,986		Feb 11 04:15 PM
Tran Yvonne	Officer	Feb 11 '25	Proposed Sale	24.43	828	20,228		Feb 11 04:13 PM
Abel Robert Lorne	Officer	Feb 10 '25	Proposed Sale	25.18	2,636	66,374		Feb 10 05:24 PM
Dugan Margaret	Chief Medical Officer	Oct 15 '24	Sale	17.78	1,531	27,226	13,469	Oct 16 05:24 PM
Dugan Margaret	Officer	Oct 15 '24	Proposed Sale	17.78	1,531	27,226		Oct 15 03:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SDGR

Schrodinger Inc

Upgrade your FINVIZ experience